Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 3 |
2015 | 1 |
2018 | 1 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.
N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665.
N Engl J Med. 2021.
PMID: 34437784
Free PMC article.
Clinical Trial.
Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis.
Graeber SY, Dopfer C, Naehrlich L, Gyulumyan L, Scheuermann H, Hirtz S, Wege S, Mairbäurl H, Dorda M, Hyde R, Bagheri-Hanson A, Rueckes-Nilges C, Fischer S, Mall MA, Tümmler B.
Graeber SY, et al. Among authors: rueckes nilges c.
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1433-1442. doi: 10.1164/rccm.201710-1983OC.
Am J Respir Crit Care Med. 2018.
PMID: 29327948
Item in Clipboard
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles.
Graeber SY, Vitzthum C, Pallenberg ST, Naehrlich L, Stahl M, Rohrbach A, Drescher M, Minso R, Ringshausen FC, Rueckes-Nilges C, Klajda J, Berges J, Yu Y, Scheuermann H, Hirtz S, Sommerburg O, Dittrich AM, Tümmler B, Mall MA.
Graeber SY, et al. Among authors: rueckes nilges c.
Am J Respir Crit Care Med. 2022 Mar 1;205(5):540-549. doi: 10.1164/rccm.202110-2249OC.
Am J Respir Crit Care Med. 2022.
PMID: 34936849
Item in Clipboard
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?
Niedermayr K, Gasser V, Rueckes-Nilges C, Appelt D, Eder J, Fuchs T, Naehrlich L, Ellemunter H.
Niedermayr K, et al. Among authors: rueckes nilges c.
Ther Adv Chronic Dis. 2022 Aug 5;13:20406223221108627. doi: 10.1177/20406223221108627. eCollection 2022.
Ther Adv Chronic Dis. 2022.
PMID: 35959505
Free PMC article.
Item in Clipboard
Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study.
Bagheri-Hanson A, Nedwed S, Rueckes-Nilges C, Naehrlich L.
Bagheri-Hanson A, et al. Among authors: rueckes nilges c.
BMC Pulm Med. 2014 Oct 4;14:156. doi: 10.1186/1471-2466-14-156.
BMC Pulm Med. 2014.
PMID: 25280757
Free PMC article.
Item in Clipboard
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.
Naehrlich L, Ballmann M, Davies J, Derichs N, Gonska T, Hjelte L, van Konigsbruggen-Rietschel S, Leal T, Melotti P, Middleton P, Tümmler B, Vermeulen F, Wilschanski M; ECFS Diagnostic Network Working Group.
Naehrlich L, et al.
J Cyst Fibros. 2014 Jan;13(1):24-8. doi: 10.1016/j.jcf.2013.08.006. Epub 2013 Sep 7.
J Cyst Fibros. 2014.
PMID: 24022019
Free article.
Item in Clipboard
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?
Keenan K, Avolio J, Rueckes-Nilges C, Tullis E, Gonska T, Naehrlich L.
Keenan K, et al. Among authors: rueckes nilges c.
J Cyst Fibros. 2015 May;14(3):310-6. doi: 10.1016/j.jcf.2014.09.006. Epub 2014 Oct 7.
J Cyst Fibros. 2015.
PMID: 25300456
Free article.
Item in Clipboard
Cite
Cite